← All stocks

Protara Therapeutics, Inc.

TARA Net buying
CIK 0001359931 #3837 in the set updated 20 Sep 2026
Bought (120 mo)
$7.29M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$4.86M
$96.14K on a plan · $882.16K straight out of an exercise
Sold at will
$3.88M
81 of 83 sales
Net
+$2.43M
+$3.41M against sales at will

By person

29 insiders · 130 transactions
4.3×

Jesse Shefferman holds only 4.3 times base salary in stock. $2.83M of shares against $654.89K in salary for 2025.

Salary from the company's own proxy. The shares are what Jesse Shefferman last reported holding, valued at $4.09, the price Common Stock was last bought or sold at on the open market here, on 29 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Opaleye Management Inc. entity
10% owner
$6.73M (31)
$1.79M (38)
+$4.94M
2,603,472
$10.65M
−6.7%
Marshall Randall
Former 10% Owner
$1.77M (40)
−$1.77M
585,600
$2.40M
Shefferman Jesse
CEO and President
$34.81K (1)
$882.16K (1) scheduled
−$847.35K
691,832
$2.83M
Zummo Jacqueline
Chief R&D Officer
$221.13K (3)
−$221.13K
94,827
$387.84K
BESHAR LUKE M
Director
$118.06K (3)
+$118.06K
198,000
$809.82K
Olivo Martin Sebastian
Chief Medical Officer
$99.97K (2)
+$99.97K
14,344
$58.67K
+222.3%
Levy Richard S
Director
$63.80K (1)
+$63.80K
51,000
$208.59K
Davis Blaine
Chief Financial Officer
$25.04K (1)
+$25.04K
20,662
$84.51K
+103.3%
Burke Steven Keith
SVP and Chief Medical Officer
$22.56K (1)
+$22.56K
128,249
$524.54K
+59.0%
Eldridge, George Arthur
Sr VP, CFO, Treasr, Asst Secy
$498.55 (1)
+$498.55
32,222
$131.79K
+481.1%
Flynn James E
Director
$193.47K (1)
$193.47K (1)
$0.00
1,224,899
$5.01M
0.0%
Opaleye, L.P.
10% owner
2,208,472
$9.03M
+47,879%
Freund John Gordon
Director
2,175,882
$8.90M
+47.8%
Abingworth LLP
Former 10% Owner
2,144,517
$8.77M
+6.3%
Haines Timothy
Former Director and 10% Owner
2,144,517
$8.77M
+6.3%
Nicacio Leonardo Viana
Chief Medical Officer
78,181
$319.76K
+3,485%
CONKLING WILLIAM
Chief Commercial Officer
69,992
$286.27K
Fabbio Patrick
Chief Financial Officer
64,115
$262.23K
Bandari Jathin
Chief Medical Officer
56,704
$231.92K
+656.1%
BOHLIN GAREN G
Director
53,312
$218.05K
Casoy Julio
Chief Medical Officer
45,500
$186.10K
Fry Hannah
VP, Controller
42,723
$174.74K
+1,543%
GARCEAU ROGER
Director
33,000
$134.97K
SARGEN GREGORY
Director
31,000
$126.79K
Kowalsky Matthew Paul
VP, Legal and Secretary
29,479
$120.57K
+851.9%
Braunstein Scott
Director
26,500
$108.39K
Solomon Michael Edward
Director
26,500
$108.39K
Toner E. Scott
Senior VP of Commercial
23,357
$95.53K
+32.9%
NOYES TIMOTHY P
President and CEO
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 20,629,772 to 59,095,488 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Zummo Jacqueline
26 Mar 2025
Chf Scientific Operations Off
Sold on a plan
21,224
$4.53
$96.14K

What was left out

Form 4 filings counted 267
Amendments (4/A) skipped 13
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 81
Transactions with no price 0
Shares from compensation/vesting 6,975,232
Sales filed before the plan box existed 43
History held since 1 Sep 2016